PROM1 and breast cancer: In the present study, TOPflash reporter activity (to measure β-catenin-dependent transcriptional activity) in the CD133+ fraction was increased 5- to 10-fold compared to the CD133− fraction in some cell lines from brain, colon and lung cancers, but not gastric or breast cancers (Figure 2C).